Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction

Sponsor
1800 Contacts, Inc. (Industry)
Overall Status
Not yet recruiting
CT.gov ID
NCT05049070
Collaborator
(none)
279
1
3

Study Details

Study Description

Brief Summary

This study evaluates the reliability, validity and safety of a self administered, subjective refraction test via a mobile medical app (GoEyes) as compared to standard of care subjective manifest refraction performed by a health care provider, in subjects who have no known ocular disease or condition other than refractive error.

Condition or Disease Intervention/Treatment Phase
  • Diagnostic Test: Mobile medical application to self administer a subjective refraction test
  • Diagnostic Test: Standard of care refraction test
N/A

Detailed Description

GoEyes is a Mobile Medical Application, which can be downloaded to a smartphone and is being developed as a self -administered subjective refraction examination that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals.

The Study will be conducted in 2 parts; Part A and Part B.

Approximately 59 participants will be enrolled In Part A. Part A participants will have a GoEyes refraction test in clinic on two separate days and will also have a standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.

Approximately 220 participants will be enrolled in Part B. Part B participants will self administer the GoEyes test at home on 2 separate days and will also have an in clinic standard of care refraction test performed by a health care provider and best corrected visual acuity assessments.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
279 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Masking Description:
The Best Corrected Visual Acuity (BCVA) assessor will be masked to GoEyes and Standard of Care refraction
Primary Purpose:
Diagnostic
Official Title:
A Prospective, Multicenter, Open Label Study to Evaluate the Reliability, Validity and Safety of Subjective Mobile Refraction Assessed by GoEyes
Anticipated Study Start Date :
Sep 1, 2021
Anticipated Primary Completion Date :
Dec 1, 2021
Anticipated Study Completion Date :
Dec 1, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: GoEyes

GoEyes Self administered refraction test + Standard of care refraction test

Diagnostic Test: Mobile medical application to self administer a subjective refraction test
GoEyes is a software as a medical device and mobile medical application, which is downloaded to a smartphone and is a self-administered subjective refraction test that measures the refractive error of the user's eyes in the home environment without any contact or help from health care professionals
Other Names:
  • GoEyes
  • Diagnostic Test: Standard of care refraction test
    Standard of care subjective manifest refraction test performed by a healthcare professional

    Outcome Measures

    Primary Outcome Measures

    1. 90% Concordance for sphere power and cylinder power (monocular) [Baseline]

    2. Descriptive statistics for concordance of cylinder axis (monocular) stratified by cylinder power [Baseline]

    3. Monocular refractive outcomes [Baseline]

      Lower confidence limit of ≥ 90% for concordance (for right and left eyes separately)

    4. Monocular visual acuity [Baseline]

      Lower confidence limit of ≥95% (for right and left eyes combined)

    5. Proportion of out-of-range eye that are correctly excluded [Baseline]

    6. Incidence of Adverse Events in Part 1 [21 days]

    7. Incidence of Adverse Events in Part 2 [8 Days]

    Secondary Outcome Measures

    1. Descriptive statistics for sphere power and cylinder power (monocular) [Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)]

    2. Descriptive statistics for cylinder axis (monocular) stratified by cylinder power [Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)]

    3. Descriptive statistics for concordance of monocular refractive outcomes (for right and left eyes separately [Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)]

    4. Descriptive statistics for monocular and binocular visual acuity (for right and left eyes combined [Baseline]

    5. Proportion of out of range eyes that are correctly excluded [Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)]

    6. Comparison of test and re-test measurements to Standard of Care (SOC) data [Baseline and Visit 2 (day 2-21 for part 1 and day 2-8 for part 2)]

    7. Rate of disagreement between GoEyes screening at home and in-clinic screening [Baseline]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 39 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    1. Males or females aged 18-39 years who currently wear glasses and/or soft contact lenses to correct refractive error

    2. Normal color vision

    3. Able to use both hands at the same time and to hear, understand and verbally respond to audio instructions

    4. Have single vision lenses only

    5. Able to provide informed consent -

    Exclusion Criteria:
    1. Have any ongoing disease or ocular condition other than refractive error

    2. Have a history of permanent vison loss

    3. Have a neurological condition affecting vision

    4. Have worn glasses since age 6 or younger

    5. Have a prism in their prescription

    6. Use Rigid gas permeable lenses or OrthoK lenses

    7. Have had laser refractive surgery or any other eye surgery

    8. Use prescription eye drops -

    Contacts and Locations

    Locations

    No locations specified.

    Sponsors and Collaborators

    • 1800 Contacts, Inc.

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    1800 Contacts, Inc.
    ClinicalTrials.gov Identifier:
    NCT05049070
    Other Study ID Numbers:
    • QAD-079
    First Posted:
    Sep 17, 2021
    Last Update Posted:
    Sep 17, 2021
    Last Verified:
    Sep 1, 2021
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by 1800 Contacts, Inc.
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Sep 17, 2021